Page 5 - Who
Global rollout of 12 bn vaccine doses largest-ever but access an issue: WHO
World Health Organization (WHO) director-general Dr Tedros Adhanom Ghebreyesus on Thursday said global roll-out of more than 12 billion COVID-19 vaccine doses is the largest and fastest in human history. Addressing the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) virtually, he flagged the issue of inequities in access to COVID-19 vaccines. The three-day event is being co-hosted by the Pune-based Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, said a statement. Global roll-out of more than 12 billion COVID-19 vaccine doses is the largest and fastest in history with an estimated 60 per cent doses produced by manufacturers in developing countries. Despite this achievement, stark inequities in access to COVID-19 vaccines remain," he said. "These inequities are due partly to the fact that globally vaccine production is too concentrated. To address this, the WHO and our partners have established the mRNA Tech
 "Global rollout of 12 bn vaccine doses largest-ever but access an issue: WHO")
New Covid variants spreading across the globe: what are the risk?
Amid the surge in the new and recombinant variants, scientists across the world are now watching out for variants which could turn into variants of concern soon
 "New Covid variants spreading across the globe: what are the risk?")
Developing nations' vaccine manufacturers bat for pandemic treaty
It's time to focus on routine immunisation: Mandaviya
 "Developing nations' vaccine manufacturers bat for pandemic treaty")
Single-dose approach: Global cholera outbreak leads to vaccine crunch
One dose of vaccine has proven effective in stopping outbreaks, even though evidence on the exact duration of protection is 'limited'.
 "Single-dose approach: Global cholera outbreak leads to vaccine crunch")
Physical inactivity may cost the world $300 bn between 2020 and 2030: WHO
Around 500 mn people will develop heart disease, obesity, diabetes or other non-communicable diseases (NCDs) due to physical inactivity, WHO's 'Global Status Report on Physical Activity 2022' says
 "Physical inactivity may cost the world $300 bn between 2020 and 2030: WHO")
After the Gambia, Nigeria, Liberia issue alerts over Maiden Pharma's syrups
Nigeria has reportedly circulated the alert across all professional bodies, health care providers and supply chain associates
 "After the Gambia, Nigeria, Liberia issue alerts over Maiden Pharma's syrups")
Drug regulator halts production at Maiden Pharma's Sonipat unit
Centre forms panel to analyse causal relation between deaths and cough syrups
 "Drug regulator halts production at Maiden Pharma's Sonipat unit")
Haryana stops production at plant making cough syrups flagged by WHO
12 violations found at Maiden Pharmaceuticals' Sonipat facility, says state health minister
 "Haryana stops production at plant making cough syrups flagged by WHO")
Who is responsible for the quality of Indian pharma exports?
WHO has issued a global alert over four cough syrups made by an Indian pharma company, for alleged death of 66 children in The Gambia. Who are responsible for quality checks of Indian pharma exports?
 "Who is responsible for the quality of Indian pharma exports?")
Top headlines: Growth forecast, Maiden Pharma cough syrup issue, and more
From World Bank slashing India's economic growth to Maiden Pharma's cough syrup issue, here are the top headlines on Friday morning
 "Top headlines: Growth forecast, Maiden Pharma cough syrup issue, and more")
Who is responsible for the quality of Indian pharma exports?
WHO has issued a global alert over four cough syrups made by an Indian pharma company, for alleged death of 66 children in The Gambia. Who are responsible for quality checks of Indian pharma exports?
Maiden Pharma's cough syrups, under WHO scanner, not sold in India: Sources
Meanwhile, the Indian regulator is awaiting evidence of links between the cough syrups and the deaths in Gambia
WHO issues alert for 4 India-made cough syrups; check symptoms here
WHO has asked not to use these four products until analysed by the relevant national regulatory authorities
Cough syrups by Indian firm potentially tied to 66 deaths in Gambia: WHO
WHO issued a medical product alert for the four syrups and said it was conducting further investigation with New Delhi-based Maiden Pharmaceuticals and regulatory authorities in India
 "Cough syrups by Indian firm potentially tied to 66 deaths in Gambia: WHO")
End of the pandemic in sight, but is it time to let down the guard?
While the world is moving away from the most basic Covid-19 protocols, some experts say it is too early to declare that the pandemic is over
 "End of the pandemic in sight, but is it time to let down the guard?")
WHO launches new initiative to stop invasive malaria vector in Africa
A new World Health Organization (WHO) initiative has been launched that aims to stop the further spread of this invasive mosquito species in the region.The WHO had identified the spread of Anopheles stephensi as a significant threat to malaria control and elimination in 2019 - particularly in Africa, where the disease hits hardest.Originally native to parts of South Asia and the Arabian Peninsula, An. stephensi has been expanding its range over the last decade, with detections reported in Djibouti (2012), Ethiopia and Sudan (2016), Somalia (2019) and Nigeria (2020).Unlike the other main mosquito vectors of malaria in Africa, it thrives in urban settings, the WHO said."With more than 40 per cent of the population in Africa living in urban environments, the WHO said the invasion and spread of An. stephensi could pose a significant threat to the control and elimination of malaria. But large-scale surveillance of the vector is still in its infancy, and more research and data are urgently .
 "WHO launches new initiative to stop invasive malaria vector in Africa")
Arogya World wins the prestigious UN award for initiative against NCD
/ -- Arogya World is thrilled to be selected as a recipient of the 2022 UN Interagency Task Force and the WHO Special Programme on Primary Health Care Award. The award recognized Arogya World for its work in scaling up community-based delivery models to strengthen prevention and control of diabetes at the population level, across 19 states in India. Expressing her views, Dr Nalini Saligram, Founder & CEO, Arogya World, said, "This is a proud moment for us, as Arogya World is the only non-profit working in India to receive this prestigious award. This is global recognition for the work that my team has been doing for more than a decade, working tirelessly on the prevention of NCDs at the population level in India. We thank Dr Venkat Narayan from Emory University for nominating us, and thank all our partners and supporters for helping us improve the health of millions of Indians throughout our vast country. This award spurs us on to do more, with a greater sense of responsibility, ..
 "Arogya World wins the prestigious UN award for initiative against NCD")
WHO researcher Rajiv Bahl is new ICMR head and secy, health research
Bahl joined WHO in 2003 where he coordinates research and guidelines development in areas of maternal, newborn, child and adolescent health; was earlier with AIIMS
 "WHO researcher Rajiv Bahl is new ICMR head and secy, health research")
Is the end of the Covid-19 pandemic in sight for India?
WHO chief has finally said that the world has never been better placed to end the Covid-19. But, are we really seeing the end of the pandemic? Should we lower our guard and shelve the masks?
 "Is the end of the Covid-19 pandemic in sight for India?")
WHO warns of '2nd disaster' in Pakistan amid fears of water-born diseases
WHO expressed grave fears over what it termed to be a "second disaster" in the flood-hit Pakistan, where massive areas are left with standing water triggering water-borne diseases
